NanoGroup S.A.
Warsaw Stock Exchange NNG.WA
NanoGroup S.A. Revenue for the year ending December 31, 2023: USD 512.00
NanoGroup S.A. Revenue is USD 512.00 for the year ending December 31, 2023, a -98.39% change year over year. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.
-
NanoGroup S.A. Revenue for the year ending December 31, 2022 was USD 31.85 K, a -73.86% change year over year.
-
NanoGroup S.A. Revenue for the year ending December 31, 2021 was USD 121.83 K, a -33.81% change year over year.
-
NanoGroup S.A. Revenue for the year ending December 31, 2020 was USD 184.07 K, a 98.82% change year over year.
-
NanoGroup S.A. Revenue for the year ending December 31, 2019 was USD 92.58 K, a 214.46% change year over year.
Key data
| Date | Revenue | Gross Profit | Operating Income | EBIT |
|---|
Market news
Loading...
Warsaw Stock Exchange: NNG.WA
| CEO | Mr. Przemyslaw Daniel Mazurek |
| IPO Date | March 14, 2018 |
| Location | Poland |
| Headquarters | Rakowiecka 36 |
| Employees | 46 |
| Sector | Health Care |
| Industries | |
Description
NanoGroup S.A. operates as a biotechnology company. It develops and licenses early-stage biotechnology and medical projects in the areas of oncology, transplantology, and blood donations to international biotech companies and pharmaceutical companies. NanoGroup S.A was incorporated in 2016 and is based in Warsaw, Poland.
Key trends
Past 5 years
StockViz Staff
January 15, 2025
Any question? Send us an email